Urolithin-A. Powerful Mitochondrial Therapy So much of our health is dependent upon the function of our mitochondria, the energy providers found in each of our cells. Keeping our mitochondria functioning well is the reason that we, for example, exercise, engage occasionally in fasting, and do our very best to eat the very best diet we can. New and exciting research has uncovered a natural, plant-based compound that is associated with significant improvement in mitochondrial function and aiding the body in getting rid of defective mitochondria, a process called my mitophagy. This chemical is called Urolithin-A, and today I have the distinct pleasure of interviewing Dr. Anurag Singh, who has done incredible work in both discovering urolithin-A as well as in conducting various human and animal studies demonstrating how potent it is in terms of nurturing mitochondrial health and functionality. Again, we need to do everything we can to prevent our mitochondria from failing. Mitochondrial dysfunction is something we certainly see in various degenerative conditions like Alzheimer's and Parkinson's, but we now have markers that indicate that mitochondria are actually suffering in common conditions like type-2 diabetes and obesity. If we are to maintain our health, we've got to focus on maintaining mitochondrial function. I think you will all agree that we now may well have a powerful new, non-prescription tool, Urolithin-A, to help us achieve that goal. I am certain that you will enjoy today's podcast and find it very empowering.  ==== 0:00 Intro 3:16 Mitochondria Study 8:55 Why Mitochondria Matter 14:48 Sources of Urolithin A 19:34 How it Was Discovered 25:00 Anti-Inflammatories & The Gut 36:30 Conclusion ==== Dr. Anurag Singh is currently Chief Medical Officer at Amazentis SA, an advanced nutrition biotech company based in Lausanne, Switzerland that discovers and develops next generation natural compounds targeting improvements in mitochondrial health. In particular, Dr. Singh has designed and led for the last 7 years the clinical development program for the natural mitophagy activator, Urolithin A (Mitopure). This work has led to the commercial launch of several branded consumer health products (Timeline, Celltrient) targeting improvements in cellular health. Dr. Singh received his medical training in Internal Medicine from the Armed Forces Medical College, Pune, India and a PhD in Immunology from the University of Connecticut in USA. He has authored 30 articles in top peer-reviewed journals, holds 10 patents and has designed and led 40 clinical trials over the last 15 yrs.See omnystudio.com/listener for privacy information.